
-
Bayonne stun champions Toulouse to go top in France
-
Greta Thunberg among Gaza flotilla detainees to leave Israel
-
Atletico draw at Celta Vigo after Lenglet red card
-
Ethan Mbappe returns to haunt PSG as Lille force draw with Ligue 1 leaders
-
Hojlund fires Napoli into Serie A lead as AC Milan held at Juve
-
Vampires, blood and dance: Bollywood horror goes mainstream
-
Broncos rally snaps Eagles unbeaten record, Ravens slump deepens
-
Former NFL QB Sanchez charged after allegedly attacking truck driver
-
France unveils new government amid political deadlock
-
Child's play for Haaland as Man City star strikes again
-
India crush Pakistan by 88 runs amid handshake snub, umpiring drama
-
Hojlund fires Napoli past Genoa and into Serie A lead
-
Sevilla rout 'horrendous' Barca in Liga thrashing
-
Haaland fires Man City to win at Brentford, Everton end Palace's unbeaten run
-
Haaland extends hot streak as Man City sink Brentford
-
Italy working hard to prevent extra US tariffs on pasta
-
Sinner out of Shanghai Masters as Djokovic battles into last 16
-
Swift rules N. America box office with 'Showgirl' event
-
Ryder Cup hero MacIntyre wins Alfred Dunhill Links on home soil
-
Republicans warn of pain ahead as US shutdown faces second week
-
Sevilla rout champions Barca in shock Liga thrashing
-
Norris-Piastri clash overshadows McLaren constructors' title win
-
Trump administration declares US cities war zones
-
Bad Bunny takes aim at Super Bowl backlash in 'SNL' host gig
-
El Khannouss fires Stuttgart into Bundesliga top four
-
Insatiable Pogacar romps to European title
-
Newcastle inflict more pain on Postecoglou, Everton end Palace's unbeaten run
-
Daryz wins Prix de l'Arc de Triomphe thriller
-
Russell wins Singapore GP as McLaren seal constructors' title
-
Landslides and floods kill 64 in Nepal, India
-
Russell wins Singapore GP, McLaren seal constructors' title
-
Djokovic 'hangs by rope' before battling into Shanghai last 16
-
Erasmus proud of Boks' title triumph as Rugby Championship faces uncertain future
-
French PM under pressure to put together cabinet
-
US Open finalist Anisimova beats Noskova to win Beijing title
-
Hamas calls for swift hostage-prisoner swap as talks set to begin
-
Opec+ plus to raise oil production by 137,000 barrels a day in November
-
Death toll from Indonesia school collapse rises to 45
-
Brisbane Broncos edge Storm in thrilling NRL grand final
-
Refreshed Sabalenka 'ready to go' after post-US Open break
-
Georgia PM vows sweeping crackdown after 'foiled coup'
-
Landslides and floods kill 63 in Nepal, India
-
No handshakes again as India, Pakistan meet at Women's World Cup
-
Georgia PM announces sweeping crackdown on opposition after 'foiled coup'
-
Syria selects members of first post-Assad parliament
-
Russian strikes kill five in Ukraine, cause power outages
-
World champion Marquez crashes out of Indonesia MotoGP
-
Babis to meet Czech president after party tops parliamentary vote
-
Death toll from Indonesia school collapse rises to 37
-
OPEC+ meets with future oil production hanging in the balance

What is microRNA? Nobel-winning discovery explained
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical breakthroughs.
But while several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses, none have actually yet reached patients.
And the world paid little attention when the new Nobel laureates Victor Ambros and Gary Ruvkun revealed their discovery decades ago, thinking it was just "something weird about worms", Cambridge University geneticist Eric Miska told AFP.
Here is an explainer about how exactly these tiny genetic switches work inside our bodies.
- What is microRNA? -
Each cell in the human body has the same set of instructions, called DNA. Some turn into brain cells, while others become muscles.
So how do the cells know what to become? The relevant part of the DNA's instructions is pointed to via a process called gene regulation.
Ribonucleic acid (RNA) normally serves as a messenger. It delivers the instructions from the DNA to proteins, which are the building blocks of life that turn cells into brains -- or muscles.
Miska gave the example of the messenger RNA vaccines rolled out against Covid-19 during the pandemic, which insert a message with new instructions to build proteins that block viruses.
But the two new Nobel winners Ambros and Ruvkun discovered a whole new type of gene regulator that had previously been overlooked by science.
Rather than being the messenger which relays information, microRNA instead acts as a switch to turn other genes off and on.
"This was a whole new level of control that we had totally missed," said Miska, who has worked on microRNA for two decades, including with the new Nobel laureates.
"The discovery of microRNAs brought an additional level of complexity by revealing that regions that were thought to be non-coding play a role in gene regulation," French researcher Benoit Ballester told AFP.
- What did the Nobel winners do? -
Back in the 1980s, Ambros and Ruvkun had been working separately on how genes interact in one-millimetre-long roundworms called C.elegans.
When they compared their work, it led to the discovery of microRNA. Ambros revealed the finding in a 1993 paper.
"Nobody really paid much attention," Miska said, explaining that most scientists at the time thought it only applied to worms.
Then in 2000, Ruvkun published research showing that microRNA is present right across the animal kingdom, including in humans and even some viruses.
"This was not just something weird that worms do, but in fact all animals and plants are totally dependent for development and normal function on them," Miska said.
More than a thousand genes that respond to microRNAs are now believed to be in the human body.
- How could this help us? -
There are numerous new treatments and tests using microRNA that are undergoing trials but none have been made widely available.
"Though there are no very clear applications available yet in microRNAs, understanding them, knowing that they exist, understanding their counter-regulatory networks, is always the first step," the Karolinska Institute's Gunilla Karlsson Hedestam told journalists in Stockholm.
MicroRNAs are particularly promising for fighting cancer because some of these switches "act as a tumour suppressor, so they put a brake on cells dividing inappropriately," Miska said.
Others, meanwhile, induce "cells to divide, which can lead to cancer", he added.
Because many viruses use microRNAs, several antiviral drugs are at varying stages of development, including for hepatitis C.
One complicating factor has been that microRNAs can be unstable.
But scientists also hope they can be used as a test called a "biomarker", which could reveal what type of cancer a patient could be suffering from, for example.
- What next? -
It also appears probable that microRNAs could be involved in the evolution of our species, Miska said.
While human brains are difficult to study, Miska hoped future research will discover more.
E.Gasser--VB